SATTER INVESTMENT MANAGEMENT
Satter Investment Management is a principal investment firm specializing in investments in life sciences and medical technology companies.
Similar Organizations
Greenstone Venture Partners
Greenstone Venture Partners is a venture capital firm specializing in investments in early stage technology companies.
LSKW Investments LP
LSKW Investment LP is a venture capital investment firm specializing in investments in the technology sector.
Yonjin Venture
Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.
Current Employees Featured
Muneer A. Satter
Muneer A. Satter Founder @ Satter Investment Management Founder 2013-10-01
Founder
Muneer A. Satter
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-08 | Annexon Biosciences | Satter Investment Management investment in Post-IPO Equity - Annexon Biosciences | 130 M USD |
2021-01-06 | Aileron Therapeutics | Satter Investment Management investment in Post-IPO Secondary - Aileron Therapeutics | 35.9 M USD |
2020-07-01 | Annexon Biosciences | Satter Investment Management investment in Series C - Annexon Biosciences | 100 M USD |
2018-12-19 | Annexon Biosciences | Satter Investment Management investment in Series C - Annexon Biosciences | 75 M USD |
2017-03-16 | Aerpio Pharmaceuticals | Satter Investment Management investment in Venture Round - Aerpio Pharmaceuticals | 40 M USD |
2016-06-23 | Annexon Biosciences | Satter Investment Management investment in Series B - Annexon Biosciences | 44 M USD |
2014-12-15 | Annexon Biosciences | Satter Investment Management investment in Series A - Annexon Biosciences | 34 M USD |
2014-04-23 | Aerpio Pharmaceuticals | Satter Investment Management investment in Series C - Aerpio Pharmaceuticals | 22 M USD |
2013-11-06 | Aerpio Pharmaceuticals | Satter Investment Management investment in Series A - Aerpio Pharmaceuticals | 36 M USD |
2013-06-04 | Akebia Therapeutics | Satter Investment Management investment in Series C - Akebia Therapeutics | 41 M USD |